Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Trump signs executive order to help reshore pharmaceutical manufacturing

By Chris Newmarker | August 10, 2020

Trump Whirlpool reshore pharmaceuticals

“We’ll be making our product here safely, beautifully, and inexpensively,” Trump said during an Aug. 6 event at a Whirlpool factory in Ohio. [Image pulled from White House video]

President Donald Trump recently signed an executive order meant to encourage the reshoring of pharmaceutical manufacturing to the U.S.

The executive order, signed Aug. 6, includes “buy American” provisions for U.S. government agencies’ procurement of essential medicines and reduces regulatory provisions.

The Secretary of Health and Human Services and FDA commissioner, consistent with applicable law, will also accelerate FDA approvals and clearances for domestic producers of medicines and medical countermeasures, issue guidance for advanced manufacturing techniques and increase inspections of manufacturing facilities outside the U.S.

“During the course of the next four years, we will bring our pharmaceutical and medical supply chains home,” Trump said during an Aug. 6 appearance at a Whirlpool washing machine factory in Clyde, Ohio. “We’re going to bring them home where they belong. And we’ll end reliance on China, just like we did with the washers and dryers, just like we did with many other things. We’ll be making our product here safely, beautifully, and inexpensively.”

Tell Us What You Think! Cancel reply

Related Articles Read More >

A Zipline fixed-wing drone in the air drops a package
Cardinal Health starts Zipline drone deliveries of drugs and medical supplies
Pfizer logo
Pfizer to spend $120M to make COVID-19 oral treatment in U.S.
Image of MedTrace Pharma's P3 automated delivery system for 15-O water in action
MedTrace Pharma moves forward on 15 O-water imaging tech
coronavirus COVID-19 Pfizer
NIH starts evaluating second COVID-19 booster shots in adults

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards